mRNA Quality Control

Introduction

Messenger RNA (mRNA) quality control (QC) is a critical step in biotechnology and biopharmaceutical manufacturing, ensuring that mRNA molecules used in vaccines, gene therapies, and research applications are intact, correctly synthesized, and free from contaminants. The assessment of mRNA quality involves detecting factors such as sequence fidelity, structural integrity, purity, and stability.

High-quality mRNA must be free from degradation, unwanted modifications (e.g., incomplete 5' capping), truncated transcripts, and contamination from residual plasmid DNA, genomic DNA or proteins. Advanced analytical techniques, including electrophoresis, quantitative PCR, liquid chromatography mass spectrometry (LC-MS), sequencing, and spectroscopic methods, are employed to verify mRNA integrity before use in clinical and research settings.

Key Methods for mRNA Quality Control

mRNA Integrity and Size Analysis

A high-resolution analytical method capable of assessing RNA integrity based on molecule length is essential for quality control, evaluating potency, and optimizing manufacturing processes.

RNA integrity by Agarose Gel Electrophoresis

• Principle: Agarose gel electrophoresis is a widely used method for evaluating total RNA integrity by running the sample on a denaturing agarose gel stained with ethidium bromide.
• Application: Used for quick visual assessment of mRNA quality in routine QC checks.

RNA integrity by Capillary Electrophoresis

• Principle: A microliter-sized injection is introduced into the capillary via voltage injection, and RNA fragments bind to a fluorescent dye as they migrate through the capillary based on size using electrophoretic separation. The fragment sizes are compared against a reference ladder containing RNA fragments of known lengths. Data acquisition and analysis are carried out using the instrument’s software, which determines the size and concentration of RNA fragments in the sample.
• Application: A high-resolution analytical method for assessing RNA integrity based on molecule length.

Sequence Fidelity and Purity Analysis

mRNA products must match the intended sequence and be free from unwanted mutations or contaminants.

Reverse Transcription Quantitative PCR (RT-qPCR)

• Principle: Converts mRNA into complementary DNA (cDNA) and amplifies target regions for quantification and detection of sequence fidelity.
• Application: Validates transcript expression levels and identifies degradation or splice variations in target regions.

Next-Generation Sequencing (NGS) and RNA-Seq

• Principle: High-throughput sequencing reads entire mRNA sequences, detecting mutations, unwanted splicing variants, or degradation patterns.
• Application: Used in mRNA vaccine and therapeutics development to verify sequence accuracy.

UV-Vis Spectrophotometry (Nanodrop A260/A280 Ratio)

• Principle: Measures RNA purity by assessing the absorbance ratio at 260 nm (nucleic acids) and 280 nm (proteins).
• Application: Assesses RNA purity, with an optimal A260/A280 ratio of ~2.0 indicating minimal protein contamination, though additional methods are needed to confirm RNA integrity.

Fluorometric RNA Quantification (Qubit Assay)

• Principle: Uses fluorescent dyes specific for RNA to accurately measure concentration.
• Application: Provides precise RNA quantification, particularly for low-concentration samples.

Structural and Chemical Modification Analysis

Modifications such as 5’ capping and poly(A) tailing affect mRNA stability and translation efficiency.

mRNA 5′- CAP by RP–LC-MS/MS

• Principle: mRNA is digested using Nuclease P1 to generate cap dinucleotides, which are then separated and quantified by LC-MS/MS.
• Application: This method enables precise detection and quantification of both ribose-methylated and unmethylated cap structures.

Percent POLY(A) TAIL Length by IP-RP-HPLC

• Principle: Perform site-specific cleavage of the mRNA molecule using ribonuclease H to generate specific smaller fragments that can be effectively separated and analyzed using IP-RP-HPLC.
• Application: The presence and length of the 3' poly(A) tail—essential for mRNA stability and efficient translation—are critical quality attributes for mRNA vaccines and can be assessed by separating and quantifying tailed and tailless mRNA using IP-RP-HPLC.

Detection of Contaminants in mRNA Samples

Ensuring that mRNA products are free from DNA, proteins, and endotoxins is crucial for pharmaceutical applications.

dsRNA by IMMUNOBLOT/ELISA

• Principle: Use antibodies that specifically recognize double-stranded RNA (dsRNA), such like J2 antibody, to detect dsRNA levels in the sample.
• Application: Double-stranded RNA (dsRNA) impurities can trigger unwanted immune responses, making it essential to detect and control their levels to ensure patient safety.

Genomic DNA Contamination Testing via qPCR

• Principle: Amplifies DNA-specific regions to detect residual genomic DNA in mRNA preparations.
• Application: Ensures mRNA purity in biopharmaceutical manufacturing.

Protein Contamination Analysis Using SDS-PAGE or Western Blot

• Principle: Detects residual protein contamination in mRNA samples.
• Application: Ensures removal of unwanted proteins after mRNA purification.

Endotoxin Testing Using Limulus Amebocyte Lysate (LAL) Assay

• Principle: Detects bacterial endotoxins that can cause immune responses in therapeutic applications.
• Application: Critical for ensuring safety in mRNA vaccines and therapeutics.

Applications of mRNA QC in Biotechnology and Medicine

• mRNA Vaccine Development: Ensures integrity and stability of synthetic mRNA used in vaccines.
• Gene Therapy: Verifies sequence fidelity and structural accuracy to prevent ineffective or harmful protein expression.
• Biopharmaceutical Manufacturing: Ensures batch-to-batch consistency in mRNA production.

GenScript Services for mRNA Quality Control

• Custom mRNA Synthesis : High-quality, optimized mRNA sequences for research and therapeutic applications.
• mRNA QC Services : Comprehensive quality assessment of mRNA integrity, purity, and functionality using advanced analytical techniques.
• 5’ Cap and Poly(A) Tail Characterization via mass spectrometry, Poly(A) Guarantee Service.
• Endotoxin Detection & Removal System : Ensures the removal of bacterial endotoxins from therapeutic mRNA preparations.

Conclusion

mRNA quality control is crucial in both research and biopharmaceutical applications, ensuring integrity, purity, and functional efficacy. A combination of electrophoresis, qPCR, sequencing, and biochemical assays provides a comprehensive assessment of mRNA quality. As mRNA-based medicines and vaccines continue to evolve, advanced QC techniques will remain essential in ensuring their safety and effectiveness.